CAR-T therapy modifications provide new promise for cancer immunotherapies
by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L
Updated on: April 09,2024
17
CAR-T therapy modifications provide new promise for cancer immunotherapies
by King's College LondonCredit: CC0 Public DomainNew research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company L
Updated on:April 09,2024
17